Press Release

Nervana Launches on Google Play, Bringing Nervous System–Based Support to People with Chronic Symptoms

The Android launch makes Nervana’s AI-powered chronic symptom support available to more people living with persistent pain, digestive issues, insomnia, fatigue, and other symptoms.

Nervana app provides a new path for chronic symptoms
San Francisco, CA / Jul 14, 2026 / Nervana

Nervana, an AI-powered digital health company  for people living with chronic symptoms, today announced its launch on Google Play, expanding access to Android users seeking a new way to understand and work with persistent symptoms through the nervous system. Nervana is already available for iOS users on the App Store.

Millions of people live with chronic pain, digestive issues, insomnia, fatigue, migraines, and other persistent symptoms without a clear path forward. Many have seen multiple doctors, tried medications, seen alternative providers, changed their diets, and still feel stuck with persistent symptoms. Often there is no damage to the body or scans appear normal, and yet symptoms persist without an explanation.

Nervana gives people a way forward when traditional care has left them without one.

Nervana was created in partnership with over 400 clinicians to provide compassionate, science-informed support in making sense of their symptoms and learning practical tools they can use in daily life. Through a mobile app centered around a trained AI voice coach, Nervana personalizes nervous system education to each user’s symptoms, history, and lived experience. Users can access guided practices such as somatic tracking, breathwork, meditation, emotional awareness, and nervous system regulation exercises, along with clear next steps to help integrate these tools outside the app.

Nervana does not replace medical care or diagnosis. Instead, it is designed as a supportive tool for people who want to better understand the role of the nervous system in chronic symptoms and practice evidence-informed mind-body approaches as part of their broader care.

Dr. David Clarke, a physician at the forefront of neuroplastic symptom recovery for the last 40 years and member of Nervana’s Clinical Advisory Board, shares, “Nervana’s launch on Google Play is a major step forward in expanding access to nervous system–based support for chronic symptoms. It’s clear in my work that many people are looking for compassionate, science-informed tools to better understand their symptoms and support their health journey. This launch allows Nervana to meet that need at a much larger scale.”

“Nervana was built by people who know what it feels like to live for years with symptoms that traditional care does not fully resolve. I lived with chronic symptoms for years until I found neuroplastic symptom relief,” said Nora Rodden, Founder and CEO of Nervana. “We wanted to create the kind of support we wish we had earlier, grounded in neuroscience, deeply compassionate, and available in the moments when people need help making sense of what is happening in their bodies.”

The Google Play launch marks an important step in Nervana’s mission to make nervous system–based chronic symptom support more accessible. Nervana is already available for iOS users on the App Store, and the Google Play launch now brings the platform to Android users.

###
About Nervana

Nervana is a neuroscience-based app designed to help people better understand their brain–body connection and learn skills that may reduce the impact of chronic neuroplastic symptoms, such as pain, IBS, fatigue, migraines, or sleep issues, after a provider has ruled out a structural cause.

Nervana combines science-based education, guided nervous-system practices, and supportive AI coaching to help you build a healthier relationship with your symptoms.

Press Contacts
Sam Kahn
sam@trynervana.com
Nervana
Nora Rodden
nora@trynervana.com
Nervana
Strategic intelligence for the future of health.

We break down how fitness, wellness, and healthcare are converging — and what it means for business, culture, and capital.

No thanks.